Printer Friendly

New Market Research Report: Global Immunoprotein Diagnostic Testing Market 2015-2019.

[USPRwire, Thu Jan 07 2016] Immunoproteins are blood proteins that are used as analytes for different disease diagnostic assays like ELISA, CLIA, immunoturbidity assay, and RIA. The market for immunoprotein diagnostic testing is positively influenced by factors like the growing elderly population and the increased incidence and prevalence of chronic diseases. These factors foster the prospects for growth in this market and results in its healthy CAGR of more than 7% by 2019.

Growing focus on early disease diagnosis is the key driver for the growth of this market. Early diagnosis by immunoprotein diagnostic devices helps in disease screening and patient care management during a disease outbreak. Advantages like its ability to reduce the total healthcare expenditure and its ability to reduce the recovery time of patients are expected to impel market growth during the forecast period.

Full Report Details at

- http://www.fastmr.com/prod/1107392_global_immunoprotein.aspx?afid=302

Application-based segmentation of the immunoprotein diagnostic testing market

* Infectious disease testing

* Oncology and endocrine testing

* Autoimmune testing

* Allergy testing

Technavio's market research analyst has estimated the infectious disease testing segment to be the largest market segment during the forecast period. The high incidence of infectious diseases is expected to result in the augmented need for novel diagnostic tests and new reagents. This recent increase in the incidence of infectious diseases is expected to result in the augmented demand for immunoprotein diagnostic tests as it helps in the early diagnosis of infectious ailments.

Geographical segmentation of the immunoprotein diagnostic testing market

* APAC

* EMEA

* Americas

In this market research report, analysts estimate the Americas to dominate the market for immunoprotein diagnostic testing during the forecast period. In the Americas, the US is considered to be the largest revenue contributor due to the high prevalence of chronic and infectious diseases in this region. Factors like the rise in laboratory automation, shift to POC rapid diagnostic tests, and increased FDA approval for new products are envisaged to account for this region's high market share of nearly 46% by 2019.

Competitive landscape and key vendors

This market is characterized by the presence of intense competition between numerous large, medium, and small-sized manufacturers that provide different type of immunoprotein diagnostic products based on technologies like ELISA, RIA, and CLIA. These vendors form partnerships and provide premium-priced products to laboratories and patients so as to establish themselves in the market.

Leading vendors in this market are -

* Beckman Coulter

* Diasorin

* Roche Diagnostics

* Siemens Healthcare

* Thermo Fisher Scientific

Copyright [c] 2016 USPRwire Provided by SyndiGate Media Inc. ( Syndigate.info ).

COPYRIGHT 2016 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:USPRwire
Date:Jan 7, 2016
Words:422
Previous Article:New Market Research Report: Germany Shoulder Reconstruction and Small Joints Market Outlook to 2021.
Next Article:New Market Research Report: Weight Management in Denmark.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters